Intensive lipid intervention in the post-ENHANCE era

Mayo Clin Proc. 2008 Aug;83(8):867-9. doi: 10.4065/83.8.867.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticholesteremic Agents / administration & dosage*
  • Atorvastatin
  • Azetidines / administration & dosage
  • Coronary Disease / prevention & control*
  • Diabetes Complications / drug therapy
  • Disease Progression
  • Drug Therapy, Combination
  • Ezetimibe
  • Fluorobenzenes / administration & dosage
  • Heptanoic Acids / administration & dosage*
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*
  • Kidney Failure, Chronic / complications
  • Practice Guidelines as Topic
  • Pyrimidines / administration & dosage
  • Pyrroles / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Rosuvastatin Calcium
  • Simvastatin / administration & dosage
  • Sulfonamides / administration & dosage

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Fluorobenzenes
  • Heptanoic Acids
  • Pyrimidines
  • Pyrroles
  • Sulfonamides
  • Rosuvastatin Calcium
  • Atorvastatin
  • Simvastatin
  • Ezetimibe